Variant report

Variant	esv2421801
Chromosome Location	chr6:44523033-44524483
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr6:44499633..44501812-chr6:44521351..44523786,2	K562	blood:
2	chr6:44521774..44524426-chr6:44524796..44527777,2	K562	blood:
3	chr6:44500312..44506091-chr6:44519423..44524807,5	K562	blood:

Extended variants
information (count: 66 )
Associated
traits (count: 95 )

Variant overlapped rSNPs/rCNVs (count:66 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs990963	chr6:44523033-44523034	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
2	rs144247349	chr6:44523064-44523065	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs374515408	chr6:44523096-44523097	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs540799088	chr6:44523100-44523101	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs117766440	chr6:44523106-44523107	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs140682936	chr6:44523120-44523121	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs377461778	chr6:44523124-44523125	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs576599021	chr6:44523138-44523139	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs116415222	chr6:44523149-44523150	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs542797272	chr6:44523156-44523157	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs114228877	chr6:44523202-44523203	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs145304153	chr6:44523216-44523217	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs6938623	chr6:44523235-44523236	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs571430675	chr6:44523247-44523248	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs532327822	chr6:44523262-44523263	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs183129668	chr6:44523265-44523266	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs187249981	chr6:44523282-44523283	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs191966427	chr6:44523287-44523288	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs183178231	chr6:44523312-44523313	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs115941352	chr6:44523315-44523316	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs187883338	chr6:44523318-44523319	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs193282145	chr6:44523346-44523347	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs34175155	chr6:44523374-44523375	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs147630306	chr6:44523413-44523414	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs6939369	chr6:44523591-44523592	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs557034580	chr6:44523610-44523611	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs911982	chr6:44523643-44523644	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
28	rs200307510	chr6:44523668-44523669	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs397755692	chr6:44523669-44523670	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs140334933	chr6:44523670-44523671	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs199515354	chr6:44523671-44523672	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs542583253	chr6:44523672-44523673	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs142170113	chr6:44523689-44523690	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs571980394	chr6:44523697-44523698	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs528246139	chr6:44523699-44523700	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs540041350	chr6:44523700-44523701	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs59323737	chr6:44523712-44523713	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs117012155	chr6:44523742-44523743	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs56693922	chr6:44523835-44523836	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
40	rs142190987	chr6:44523889-44523890	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs184264402	chr6:44523928-44523929	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs554302466	chr6:44523930-44523931	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs73436114	chr6:44523976-44523977	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs548563131	chr6:44523991-44523992	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs529976663	chr6:44523994-44523995	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs538660713	chr6:44524022-44524023	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs567172356	chr6:44524041-44524042	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs137977107	chr6:44524092-44524093	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs534341319	chr6:44524095-44524096	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs543502274	chr6:44524150-44524151	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:95)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21720365	CNVD
Osteosarcoma	21197465	CNVD
Gastric cancer	24379144	CNVD
Neuroblastoma	18923191	CNVD
abnormal development	18461090	CNVD
Breast cancer	17603634	CNVD
Breast cancer	21364760	CNVD
Colorectal cancer	16790693	CNVD
Congenital adrenal hyperplasia	18478071	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Systemic lupus erythematosus	19287148	CNVD
Colorectal cancer	19359472	CNVD
Multiple myeloma	16616336	CNVD
Chordoma	18071362	CNVD
Follicular lymphoma	16790693	CNVD
Osteosarcoma	19286668	CNVD
Neurocytoma	17123091	CNVD
Myelofibrosis	22110671	CNVD
Cutaneous T-cell lymphoma	21881587	CNVD
Ovarian cancer	20844748	CNVD
lymphocytic leukemia	21291569	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Gastrointestinal stromal cancer	20818650	CNVD

Chromatin state (count:18 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:44513400-44523800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr6:44520600-44526600	Weak transcription	iPS-15b Cell Line	embryonic stem cell
3	chr6:44522400-44523200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
4	chr6:44522400-44523200	Enhancers	Fetal Muscle Leg	muscle
5	chr6:44522400-44523200	Enhancers	HSMMtube	muscle
6	chr6:44523000-44531000	Weak transcription	Ovary	ovary
7	chr6:44523200-44526200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
8	chr6:44523600-44524600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
9	chr6:44523800-44524000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
10	chr6:44523800-44524000	Enhancers	Gastric	stomach
11	chr6:44523800-44524000	Enhancers	Pancreas	Pancrea
12	chr6:44523800-44524200	Enhancers	Primary hematopoietic stem cells short term culture	blood
13	chr6:44523800-44527200	Enhancers	Primary hematopoietic stem cells	blood
14	chr6:44523800-44527600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
15	chr6:44524000-44525000	Weak transcription	Pancreas	Pancrea
16	chr6:44524000-44527400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr6:44524000-44531000	Weak transcription	Gastric	stomach
18	chr6:44524200-44525400	Weak transcription	Primary hematopoietic stem cells short term culture	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links